1. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with normal cerebrospinal-fluid pressure. A treatable syndrome. N Engl J Med 1965;273:117-126.
2. Katzman R. In: Katzman R, Rowe JW, editor. Diagnosis and management of dementia. Principles of geriatric neurology 1992;Philadelphia: Davis. 167-210.
3. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D. Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypo-thesis. Lancet Neurol 2003;2:506-511.
4. Symon L, Dorsch NW. Use of long-term intracranial pressure measurement to assess hydrocephalic patients prior to shunt surgery. J Neurosurg 1975;42:258-273.
5. Sklar FH, Diehl JT, Beyer CW Jr, Clark WK. Brain elasticity changes with ventriculomegaly. J Neurosurg 1980;53:173-179.
6. Tamaki N, Kusunoki T, Wakabayashi T, Matsumoto S. Cerebral hemodynamics in normal-pressure hydrocephalus. Evaluation by 133Xe inhalation method and dynamic CT study. J Neurosurg 1984;61:510-514.
7. Kitagaki H, Mori E, Ishii K, Yamaji S, Hirono N, Imamura T. CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry. AJNR Am J Neuroradiol 1998;19:1277-1284.
8. Algin O, Hakyemez B, Parlak M. Phase-contrast MRI and 3D-CISS versus contrast-enhanced MR cisternography on the evaluation of the aqueductal stenosis. Neuroradiology 2010;52:99-108.
9. Hong YJ, Yoon B, Shim YS, Cho AH, Lim SC, Ahn KJ, Yang DW. Differences in microstructural alterations of the hippocampus in Alzheimer disease and idiopathic normal pressure hydrocephalus: a diffusion tensor imaging study. AJNR Am J Neuroradiol 2010;31:1867-1872.
10. Ishikawa M. Guideline Committe for Idiopathic Normal Pressure Hydrocephalus, Japanese Society of Normal Pressure Hydrocephalus. Clinical guidelines for idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo) 2004;44:222-223.
11. Marmarou A, Black P, Bergsneider M, Klinge P, Relkin N. International NPH Consultant Group. Guidelines for management of idiopathic normal pressure hydrocephalus: progress to date. Acta Neurochir Suppl 2005;95:237-240.
12. Black PM. In: Scott RM, editor. Congress of Neurological Surgeons. The normal pressure hydrocephalus syndrome. Hydrocephalus 1990;Baltimore: Williams & Wilkins. 109-114.
13. McQuarrie IG, Saint-Louis L, Scherer PB. Treatment of normal pressure hydrocephalus with low versus medium pressure cerebrospinal fluid shunts. Neurosurgery 1984;15:484-488.
14. Petersen RC, Mokri B, Laws ER Jr. Surgical treatment of idiopathic hydrocephalus in elderly patients. Neurology 1985;35:307-311.
15. Thomas-Anterion C, Moreaud O. Idiopathic normal pressure hydrocephalus. Rev Prat 2006;56:1051-1056.
16. Ishikawa E, Yanaka K, Sugimoto K, Ayuzawa S, Nose T. Reversible dementia in patients with chronic subdural hematomas. J Neurosurg 2002;96:680-683.
17. Ooba S, Shiomi N, Shigemori M. Clinical features and surgical results of chronic subdural hematoma in the extremely aged patients. No Shinkei Geka 2006;34:273-278.
18. Noble JM, Canoll P, Honig LS. Brain tumor-associated dementia. Sci Aging Knowledge Environ 2005;2005:dn2.
19. Silverberg GD, Levinthal E, Sullivan EV, Bloch DA, Chang SD, Leverenz J, Flitman S, Winn R, Marciano F, Saul T, Huhn S, Mayo M, McGuire D. Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology 2002;59:1139-1145.
20. Pratico D, Yao Y, Rokach J, Mayo M, Silverberg GG, McGuire D. Reduction of brain lipid peroxidation by CSF drainage in Alzheimer's disease patients. J Alzheimers Dis 2004;6:385-389.
21. Bateman GA. The role of altered impedance in the pathophysiology of normal pressure hydrocephalus, Alzheimer's disease and syringomyelia. Med Hypotheses 2004;63:980-985.
22. Chakravarty A. Unifying concept for Alzheimer's disease, vascular dementia and normal pressure hydrocephalus - a hypothesis. Med Hypotheses 2004;63:827-833.
23. Harbaugh RE, Reeder TM, Senter HJ, Knopman DS, Baskin DS, Pirozzolo F, Chui HC, Shetter AG, Bakay RA, Leblanc R. Intracerebroventricular bethanechol chloride infusion in Alzheimer's disease. Results of a collaborative double-blind study. J Neurosurg 1989;71:481-486.
24. Goldsmith HS. Omental transposition in treatment of Alzheimer disease. J Am Coll Surg 2007;205:800-804.
25. Waldau B, Shetty AK. Behavior of neural stem cells in the Alzheimer brain. Cell Mol Life Sci 2008;65:2372-2384.
26. Sjogren MJ, Hellstrom PT, Jonsson MA, Runnerstam M, Silander HC, Ben-Menachem E. Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study. J Clin Psychiatry 2002;63:972-980.
27. Merrill CA, Jonsson MA, Minthon L, Ejnell H, C-son Silander H, Blennow K, Karlsson M, Nordlund A, Rolstad S, Warkentin S, Ben-Menachem E, Sjogren MJ. Vagus nerve stimulation in patients with Alzheimer's disease: additional follow-up results of a pilot study through 1 year. J Clin Psychiatry 2006;67:1171-1178.
28. Hamani C, McAndrews MP, Cohn M, Oh M, Zumsteg D, Shapiro CM, Wennberg RA, Lozano AM. Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann Neurol 2008;63:119-123.
29. Sauvage MM, Fortin NJ, Owens CB, Yonelinas AP, Eichenbaum H. Recognition memory: opposite effects of hippocampal damage on recollection and familiarity. Nat Neurosci 2008;11:16-18.
30. Bischofberger J. Young and excitable: new neurons in memory networks. Nat Neurosci 2007;10:273-275.